We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Privia Health
PRVA
$2.6B
| $424K | ﹤0.01% |
24,401
+2,016
| +9% | +$35.7K |
|
1352
Comtech Telecommunications
CMTL
$44.6M
| $422K | ﹤0.01% |
139,153
-632
| -0.5% | -$1.5K |
|
|
MZTI
1353
The Marzetti Company
MZTI
$2.81B
| $421K | ﹤0.01% |
2,230
+125
| +6% | +$23.9K |
|
1354
Boston Beer
SAM
$1.75B
| $418K | ﹤0.01% |
1,371
-98
| -7% | -$28.1K |
|
1355
New Jersey Resources
NJR
$5.43B
| $418K | ﹤0.01% |
9,781
-1,769
| -15% | -$76.3K |
|
1356
United Airlines
UAL
$34.5B
| $418K | ﹤0.01% |
8,585
+8,532
| +16,098% | +$429K |
|
1357
Citizens Financial Group
CFG
$28.2B
| $412K | ﹤0.01% |
11,445
-13,669
| -54% | -$477K |
|
1358
FirstCash
FCFS
$9.53B
| $412K | ﹤0.01% |
3,925
+1,064
| +37% | +$126K |
|
1359
Progress Software
PRGS
$1.72B
| $411K | ﹤0.01% |
7,578
+6,977
| +1,161% | +$354K |
|
1360
AutoNation
AN
$6.46B
| $408K | ﹤0.01% |
2,559
-492
| -16% | -$80.3K |
|
1361
Roivant Sciences
ROIV
$28.6B
| $404K | ﹤0.01% |
38,210
+894
| +2% | +$9.8K |
|
1362
Pitney Bowes
PBI
$2.37B
| $403K | ﹤0.01% |
79,420
+5,073
| +7% | +$24.2K |
|
1363
First Financial Corp
THFF
$914M
| $400K | ﹤0.01% |
10,842
-766
| -7% | -$28.1K |
|
1364
Kinder Morgan
KMI
$68.4B
| $398K | ﹤0.01% |
20,012
-849
| -4% | -$16.2K |
|
1365
Perrigo
PRGO
$1.88B
| $396K | ﹤0.01% |
15,439
-464
| -3% | -$13.6K |
|
1366
Nexstar Media Group
NXST
$5.04B
| $396K | ﹤0.01% |
2,384
-1,350
| -36% | -$219K |
|
1367
Ventas
VTR
$45.2B
| $394K | ﹤0.01% |
7,678
+4,013
| +109% | +$188K |
|
|
SFIX
1368
Stitch Fix
SFIX
$388M
| $393K | ﹤0.01% |
94,624
+6,739
| +8% | +$18.3K |
|
1369
Rayonier
RYN
$5.96B
| $392K | ﹤0.01% |
14,858
-798
| -5% | -$21.9K |
|
1370
Vishay Precision Group
VPG
$813M
| $391K | ﹤0.01% |
12,861
| – | – |
|
1371
Marriott International
MAR
$87.3B
| $390K | ﹤0.01% |
1,613
-199
| -11% | -$47.8K |
|
1372
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.1B
| $386K | ﹤0.01% |
+5,000
| New | +$384K |
|
1373
Carter's
CRI
$1.07B
| $379K | ﹤0.01% |
6,120
+18
| +0.3% | +$1.25K |
|
1374
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $374K | ﹤0.01% |
8,777
| – | – |
|
|
MRSN
1375
DELISTED
Mersana Therapeutics
MRSN
| $373K | ﹤0.01% |
7,420
+7,413
| +105,900% | +$536K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.